ICU Medical, Inc.
ICUI
$133.31
$2.001.52%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -12.32% | -14.15% | -8.85% | -7.98% | 6.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -12.32% | -14.15% | -8.85% | -7.98% | 6.71% |
| Cost of Revenue | -17.89% | -16.10% | -12.54% | -12.40% | 3.46% |
| Gross Profit | -1.85% | -10.68% | -1.94% | 0.31% | 13.42% |
| SG&A Expenses | -1.70% | -1.91% | -6.11% | -0.10% | -0.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.09% | -11.84% | -10.19% | -8.73% | 2.53% |
| Operating Income | 2.69% | -43.36% | 27.18% | 9.46% | 414.97% |
| Income Before Tax | 57.99% | -323.77% | 77.39% | 286.95% | 70.34% |
| Income Tax Expenses | -859.61% | -108.28% | -104.37% | -37.11% | 69.07% |
| Earnings from Continuing Operations | 294.70% | 33.97% | 89.70% | 265.08% | 60.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 294.70% | 33.97% | 89.70% | 265.08% | 60.79% |
| EBIT | 2.69% | -43.36% | 27.18% | 9.46% | 414.97% |
| EBITDA | 1.74% | -22.34% | 1.13% | -4.18% | 28.98% |
| EPS Basic | 292.93% | 34.49% | 89.81% | 263.41% | 61.30% |
| Normalized Basic EPS | 105.40% | -74.07% | 251.54% | 495.03% | 128.79% |
| EPS Diluted | 290.26% | 35.06% | 89.63% | 262.50% | 61.31% |
| Normalized Diluted EPS | 101.98% | -74.07% | 251.54% | 494.03% | 128.79% |
| Average Basic Shares Outstanding | 0.92% | 0.80% | 1.01% | 1.03% | 1.31% |
| Average Diluted Shares Outstanding | 2.62% | 0.80% | 1.01% | 1.29% | 1.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |